Analytical Performance and Clinical Utility of a Bioassay for Thyroid-Stimulating Immunoglobulins
Open Access
- 1 February 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 139 (2), 192-200
- https://doi.org/10.1309/ajcpzut7cnueu7op
Abstract
The analytical performance and the clinical utility of a thyrotropin receptor (TSHR)–stimulating immunoglobulin (TSI) bioassay were compared with those of a TSHR-binding inhibitory immunoglobulin (TBII) assay. Limits of detection (LoD) and quantitation (LoQ), assay cutoff, and the half-maximal effective concentration (EC50) were measured. Dilution analysis was performed in sera of hyperthyroid patients with Graves disease (GD) during antithyroid treatment (ATD). Titer was defined as the first dilution step at which measurement of TSI or TBII fell below the assay cutoff. The LoD, LoQ, cutoff, and EC50 of the bioassay were 251-, 298-, 814-, and 827-fold lower than for the TBII assay. There were 22%, 42%, 23%, and 14% more positive samples in the TSI bioassay at dilutions of 1:3, 1:9, 1:27, and 1:81 (P < .0001), respectively. Responders to ATD demonstrated marked differences in titers compared with nonresponders. The bioassay detected lower levels of TSHR autoantibodies, and the dilution analysis provided similar predictive values of both assays in GD.Keywords
This publication has 31 references indexed in Scilit:
- Novel chimeric thyroid-stimulating hormone-receptor bioassay for thyroid-stimulating immunoglobulinsClinical and Experimental Immunology, 2010
- A Novel Bioreporter Assay for Thyrotropin Receptor Antibodies Using a Chimeric Thyrotropin Receptor (Mc4) Is More Useful in Differentiation of Graves' Disease from Painless Thyroiditis Than Conventional Thyrotropin-Stimulating Antibody Assay Using Porcine Thyroid CellsThyroid®, 2010
- The Genetics of the Thyroid Stimulating Hormone Receptor: History and RelevanceThyroid®, 2010
- Reproducibility of Elecsys®Anti-TSHR Test Results in a Lot-to-Lot ComparisonHormone and Metabolic Research, 2010
- Evidence that Shed Thyrotropin Receptor A Subunits Drive Affinity Maturation of Autoantibodies Causing Graves’ DiseaseJournal of Clinical Endocrinology & Metabolism, 2009
- Predictors of autoimmune disease: Autoantibodies and beyondAutoimmunity, 2008
- Relevance of TSH Receptor Stimulating and Blocking Autoantibody Measurement for the Prediction of Relapse in Graves’ DiseaseHormone and Metabolic Research, 2005
- Prediction of Remission or Relapse for Graves’ Hyperthyroidism by the Combined Determination of Stimulating, Blocking and Binding TSH-Receptor Antibodies after the Withdrawal of Antithyroid Drug TreatmentHormone and Metabolic Research, 2002
- The Prognostic Value of Thyrotropin Receptor Antibody Measurement in the Early Stages of Treatment of Graves' Disease with Antithyroid DrugsThyroid®, 1998
- Clinical Utility of Thyrotropin-Receptor Antibody Assays: Comparison of Radioreceptor and Bioassay MethodsMayo Clinic Proceedings, 1988